An ELISA‐Inspired Self‐Propagating Click‐Fluoresce‐and‐Release Assay for the Ultrasensitive Detection of CD13 in Lung Cancer Patient Plasma

M Miao Liu (Department of Genetics, Yale University School of Medicine, New Haven, CT, USA.) D Dongguang Fan R Runhong Zhou (AIDS Institute, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong) W Wei Peng (Andlinger Center for Energy and the Environment, Princeton University) Y Yan Huang S Shiping He (College of Pharmaceutical Science Soochow University Suzhou Jiangsu China) F Fan Xu (CAS Key Laboratory of Colloid, Interface and Thermodynamics) S Saisai Guo (Department of Immunology, Institute of Medicinal Biotechnology Chinese Academy of Medical Sciences & Peking Union Medical College Beijing China) Y Yongyou Wu (Department of Gastrointestinal Surgery The Second Affiliated Hospital of Soochow University Suzhou Jiangsu China) S Shan Cen (Department of Immunology, Institute of Medicinal Biotechnology Chinese Academy of Medical Sciences & Peking Union Medical College Beijing China) X Xingyue Ji

Abstract

ABSTRACT Reaction‐based fluorescent probes often suffer from limited sensitivity in biomarker detection due to slow reaction kinetics and inherent stoichiometric constraints. Inspired by the decoupling of capture and detection in the enzyme‐linked immunosorbent assay (ELISA), we developed a click fluoresce and release (CFR) system, which is a two‐step detection platform comprising a capture probe and a detection probe. The capture probe converts the detection of an enzyme biomarker into the detection of tetrazine, which is then specifically recognized by the detection probe through a fluorogenic click reaction. Importantly, this click reaction simultaneously regenerates a molecule of tetrazine, establishing a self‐propagating cycle for signal amplification. CFR demonstrates superior detection limits and enhanced ability to discriminate low biomarker levels compared to conventional reaction‐based fluorescent probes, as validated by ultrasensitive detection of CD13 in complex biofluids. Notably, with this strategy, we found that plasma CD13 levels are significantly elevated in advanced lung cancer patients compared with early‐stage patients and healthy participants. Given its modular design, CFR can be readily adapted for the sensitive detection of various biomarkers by simply replacing the capture probe.

Article Details

Volume / Issue Vol. 1, Issue 1
Published August 05, 2026
ISSN 1433-7851
Publisher Wiley

Journal Info

Angewandte Chemie International Edition

Wiley

ISSN: 1433-7851 Physical Sciences

Authors (11)

M

Miao Liu

Department of Genetics, Yale University School of Medicine, New Haven, CT, USA.

D

Dongguang Fan

R

Runhong Zhou

AIDS Institute, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong

W

Wei Peng

Andlinger Center for Energy and the Environment, Princeton University

Y

Yan Huang

S

Shiping He

College of Pharmaceutical Science Soochow University Suzhou Jiangsu China

F

Fan Xu

CAS Key Laboratory of Colloid, Interface and Thermodynamics

S

Saisai Guo

Department of Immunology, Institute of Medicinal Biotechnology Chinese Academy of Medical Sciences & Peking Union Medical College Beijing China

Y

Yongyou Wu

Department of Gastrointestinal Surgery The Second Affiliated Hospital of Soochow University Suzhou Jiangsu China

S

Shan Cen

Department of Immunology, Institute of Medicinal Biotechnology Chinese Academy of Medical Sciences & Peking Union Medical College Beijing China

X

Xingyue Ji